EQ Equillium Inc

Price (delayed)

$3.16

Market cap

$199.8M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.26

Enterprise value

$139.17M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 3

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium is developing ...

Highlights
The equity has soared by 108% from the previous quarter
The quick ratio has soared by 78% from the previous quarter
Equillium's debt has surged by 135% YoY but it has decreased by 3.8% QoQ
EQ's net income is down by 36% year-on-year but it is up by 15% since the previous quarter
The gross profit has plunged by 100% YoY
Equillium's revenue has plunged by 100% YoY

Key stats

What are the main financial stats of EQ

EQ stock price

How has the Equillium stock price performed over time
Intraday
1.61%
1 week
11.27%
1 month
50.48%
1 year
756.37%
YTD
103.87%
QTD
58%

Financial performance

How have Equillium's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$20.38M
Net income
-$19.06M
Gross margin
N/A
Net margin
N/A
The gross profit has plunged by 100% YoY
Equillium's revenue has plunged by 100% YoY
The operating income has declined by 42% year-on-year but it is up by 14% since the previous quarter
EQ's net income is down by 36% year-on-year but it is up by 15% since the previous quarter

Price vs fundamentals

How does EQ's price correlate with its fundamentals

Growth

What is Equillium's growth rate over time

Valuation

What is Equillium stock price valuation
P/E
N/A
P/B
3.36
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 35% year-on-year and by 33% since the previous quarter
The equity has soared by 108% from the previous quarter
The price to book (P/B) is 74% higher than the 5-year quarterly average of 1.9 and 27% higher than the last 4 quarters average of 2.6
Equillium's revenue has plunged by 100% YoY

Efficiency

How efficient is Equillium business performance
The ROE has grown by 48% from the previous quarter and by 17% YoY
The company's return on assets rose by 43% QoQ but it fell by 15% YoY

Dividends

What is EQ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EQ.

Financial health

How did Equillium financials performed over time
The total assets has surged by 98% since the previous quarter
The quick ratio has soared by 78% from the previous quarter
Equillium's debt is 99% lower than its equity
Equillium's debt has surged by 135% YoY but it has decreased by 3.8% QoQ
The equity has soared by 108% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.